EQUITIES

Robust. Fundamental. Dynamic.

Our teams exercise independent thought with high conviction, resulting in portfolios that we believe are well positioned to address our clients' challenges – all within robust risk control frameworks.

vd-icon_Currency_CashUSD

$254.2bn
Equities Assets Under Management

vd-icon_People_3_Group v3

155
Equities Investment
Professionals

vd-icon_Bulleye_Target v3

18
Average Years’ Financial
Industry Experience

As at September 30, 2025

<span class="notranslate">no data</span>

$254.2bn
Equities Assets Under Management

148

155
Equities Investment
Professionals

19

18
Average Years’ Financial
Industry Experience

As at September 30, 2025

We measure success by a single factor: client outcomes. As a pure asset manager, our sole mission is to deliver consistent long-term risk-adjusted returns that exceed our benchmarks and peers, regardless of the prevailing investment landscape.

Featured strategies

Global Life Sciences

By understanding the science and business of health care, our experienced team seeks to invest in companies addressing unmet medical needs or improving efficiencies.

Global Technology Leaders

A global approach to investing in technology companies from a highly experienced team.

Insights

Will strong earnings growth and policy credibility drive Japanese stocks higher in 2026?

Reasons why Japanese stocks ae positioned for another year of attractive returns in 2026.

JH Explorer: Sydney office market reflects the flight to quality trend

Sydney’s office market is facing muted future supply and a flight-to-quality.

What could drive U.S. small cap returns in 2026?

Jonathan Coleman explores key drivers that could support U.S. small-cap performance in 2026, including reshoring trends, M&A activity, and AI productivity gains.